A Chemically Stable Fluorescent Mimic of Dihydroartemisinin, Artemether, and Arteether with Conserved Bioactivity and Specificity Shows High Pharmacological Relevance to the Antimalarial Drugs.

Plasmodium artemisinin drugs fluorescent imaging stability

Journal

ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580

Informations de publication

Date de publication:
10 07 2020
Historique:
pubmed: 9 4 2020
medline: 24 6 2021
entrez: 9 4 2020
Statut: ppublish

Résumé

Three novel tracers designed as fluorescent surrogates of artemisinin-derived antimalarial drugs (i.e., dihydroartemisinin, artemether, arteether, and artemisone) were synthesized from dihydroartemisinin. One of these tracers, corresponding to a dihydroartemisinin/artemether/arteether mimic, showed a combination of excellent physicochemical and biological properties such as hydrolytic stability, high inhibitory potency against blood-stage parasites, similar ring-stage survival assay values than the clinical antimalarials, high cytopermeability and specific labeling of live

Identifiants

pubmed: 32267151
doi: 10.1021/acsinfecdis.9b00430
doi:

Substances chimiques

Antimalarials 0
Artemisinins 0
artenimol 6A9O50735X
Artemether C7D6T3H22J
artemotil XGL7GFB9YI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1532-1547

Auteurs

Abdoulaye Sissoko (A)

Université de Paris, MERIT, IRD, F-75006 Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Pedro Vásquez-Ocmín (P)

Université Paris-Saclay, CNRS, BioCIS, F-92290 Châtenay-Malabry, France.

Alexandre Maciuk (A)

Université Paris-Saclay, CNRS, BioCIS, F-92290 Châtenay-Malabry, France.

Daniela Barbieri (D)

Laboratoire d'Excellence GR-Ex, Paris, France.
Université de Paris, U1016, INSERM, and UMR 8104, CNRS, F-75014 Paris, France.

Gaëlle Neveu (G)

Laboratoire d'Excellence GR-Ex, Paris, France.
Université de Paris, U1016, INSERM, and UMR 8104, CNRS, F-75014 Paris, France.

Laurine Rondepierre (L)

Université de Paris, MERIT, IRD, F-75006 Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Raphaël Grougnet (R)

Université de Paris, CiTCoM, CNRS, F-75006 Paris, France.

Pascale Leproux (P)

Université de Paris, CiTCoM, CNRS, F-75006 Paris, France.

Magali Blaud (M)

Université de Paris, CiTCoM, CNRS, F-75006 Paris, France.

Karim Hammad (K)

Université de Paris, CiTCoM, CNRS, F-75006 Paris, France.

Sylvie Michel (S)

Université de Paris, CiTCoM, CNRS, F-75006 Paris, France.

Catherine Lavazec (C)

Laboratoire d'Excellence GR-Ex, Paris, France.
Université de Paris, U1016, INSERM, and UMR 8104, CNRS, F-75014 Paris, France.

Jérôme Clain (J)

Université de Paris, MERIT, IRD, F-75006 Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Sandrine Houzé (S)

Université de Paris, MERIT, IRD, F-75006 Paris, France.
CNR du Paludisme, AP-HP, Hôpital Bichat - Claude-Bernard, F-75018 Paris, France.

Romain Duval (R)

Université de Paris, MERIT, IRD, F-75006 Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Articles similaires

Humans Female Pregnancy Adult Cameroon
1.00
Antimalarials Plasmodium falciparum Aminoquinolines Protozoan Proteins Humans
Uganda COVID-19 Humans Malaria Interrupted Time Series Analysis
Chloroquine Malaria, Vivax Plasmodium vivax Nucleic Acid Amplification Techniques Drug Resistance

Classifications MeSH